AU2002235795A1 - A method for the manufacture of compositions containing low concentrations of salts - Google Patents

A method for the manufacture of compositions containing low concentrations of salts

Info

Publication number
AU2002235795A1
AU2002235795A1 AU2002235795A AU2002235795A AU2002235795A1 AU 2002235795 A1 AU2002235795 A1 AU 2002235795A1 AU 2002235795 A AU2002235795 A AU 2002235795A AU 2002235795 A AU2002235795 A AU 2002235795A AU 2002235795 A1 AU2002235795 A1 AU 2002235795A1
Authority
AU
Australia
Prior art keywords
ion
exchanger
liquid
substance
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002235795A
Other languages
English (en)
Inventor
Makonnen Belew
Bo-Lennart Johansson
Jean-Luc Maloisel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Amersham Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004933A external-priority patent/SE0004933D0/xx
Application filed by Amersham Bioscience AB filed Critical Amersham Bioscience AB
Publication of AU2002235795A1 publication Critical patent/AU2002235795A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/04—Processes using organic exchangers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/04—Processes using organic exchangers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Seasonings (AREA)
AU2002235795A 2000-12-31 2001-12-19 A method for the manufacture of compositions containing low concentrations of salts Abandoned AU2002235795A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004933-8 2000-12-31
SE0004933A SE0004933D0 (sv) 2000-07-17 2000-12-31 A method for the manufacture of compositions containing low concentrations of salt
PCT/EP2001/015015 WO2002053288A2 (en) 2000-12-31 2001-12-19 A method for the manufacture of compositions containing low concentrations of salts

Publications (1)

Publication Number Publication Date
AU2002235795A1 true AU2002235795A1 (en) 2002-07-16

Family

ID=20282508

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002235795A Abandoned AU2002235795A1 (en) 2000-12-31 2001-12-19 A method for the manufacture of compositions containing low concentrations of salts

Country Status (9)

Country Link
US (1) US6852230B2 (enExample)
EP (1) EP1345694B1 (enExample)
JP (1) JP2004532182A (enExample)
AT (1) ATE334746T1 (enExample)
AU (1) AU2002235795A1 (enExample)
CA (1) CA2431662A1 (enExample)
DE (1) DE60121999T2 (enExample)
ES (1) ES2267840T3 (enExample)
WO (1) WO2002053288A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004018616D1 (de) * 2003-03-05 2009-02-05 Ge Healthcare Bio Sciences Ab Verfahren zur herstellung von multimodalen anionenaustauschliganden
SE0300612D0 (sv) * 2003-03-05 2003-03-05 Amersham Biosciences Ab A method of preparing ligands for hydrophobic interaction chromatography
SE0300624D0 (sv) * 2003-03-05 2003-03-05 Amersham Biosciences Ab A method of preparing affinity ligands
US7045059B2 (en) * 2003-07-28 2006-05-16 Sielc Technologies Corp Universal bonded phase material for chromatographic separation
NZ548126A (en) * 2004-02-27 2009-10-30 Ge Healthcare Bio Sciences Ab A process for the purification of antibodies involving addition of a second resin
SE0400501D0 (sv) * 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
SE529259C2 (sv) * 2005-08-31 2007-06-12 Ge Healthcare Bio Sciences Ab Tillverkning av kromarografimatriser, en kromarografimatris, en vätskekromatografikolonn, prcess för att isolera målföreningar och användning av en kromarografimatris för vätskekromatografi
EP2152405B2 (de) * 2007-05-25 2017-04-05 Merck Patent GmbH Mischpfropfpolymere für die kationenaustauschchromatographie
US20110155668A1 (en) * 2008-07-08 2011-06-30 Ge Healthcare Bio-Sciences Ab Separation medium for chromatography of various biomolecules
US20100029371A1 (en) * 2008-08-01 2010-02-04 Gennady Medvinsky Personal Game Services Commerce System (PGSCS)
JP5826180B2 (ja) * 2009-10-12 2015-12-02 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ 分離マトリックス
CN102762268B (zh) 2009-12-07 2015-07-08 弗雷塞尼斯医疗保健控股公司 使用锆离子交换吸附剂的水净化筒
EP2536499A4 (en) * 2010-02-19 2013-08-14 Ge Healthcare Bio Sciences Ab METHOD FOR PRODUCING CHROMATOGRAPHIC MEDIA
CA2906574C (en) 2013-03-15 2021-08-31 Matthew R. Dreher Imageable embolic microsphere
DE102016004432A1 (de) 2016-04-12 2017-10-12 Sartorius Stedim Biotech Gmbh Multimodales Adsorptionsmedium mit multimodalen Liganden, Verfahren zu dessen Herstellung und dessen Verwendung
EP3492166A4 (en) 2016-08-01 2020-03-11 Kaneka Corporation ADSORBENT FOR CALCIPROTEIN PARTICLES, ADSORPTION REMOVAL SYSTEM AND METHOD OF USE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3234199A (en) * 1958-12-18 1966-02-08 Allen F Reid Ion exchange process for separating proteins
JPS5927830A (ja) * 1982-08-09 1984-02-14 Cosmo Co Ltd 抗腫瘍性糖蛋白質物質
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
DK114392D0 (da) * 1992-09-17 1992-09-17 Kem En Tec As Isolering af biomolekyler
US5652348A (en) * 1994-09-23 1997-07-29 Massey University Chromatographic resins and methods for using same
GB9707696D0 (en) * 1997-04-16 1997-06-04 Agner Erik Improvements in or relating to chromatography
SE9802214D0 (sv) * 1998-06-18 1998-06-18 Amersham Pharm Biotech Ab Jonbytare och användning därav
US6310199B1 (en) 1999-05-14 2001-10-30 Promega Corporation pH dependent ion exchange matrix and method of use in the isolation of nucleic acids
SE9904197D0 (sv) * 1999-11-22 1999-11-22 Amersham Pharm Biotech Ab A method for anion exchange adsorption on matrices carrying mixed mode ligands
SE0002688D0 (sv) 2000-07-17 2000-07-17 Amersham Pharm Biotech Ab Adsorption method and ligands

Also Published As

Publication number Publication date
DE60121999T2 (de) 2007-07-26
DE60121999D1 (de) 2006-09-14
EP1345694A2 (en) 2003-09-24
US6852230B2 (en) 2005-02-08
WO2002053288A2 (en) 2002-07-11
ATE334746T1 (de) 2006-08-15
JP2004532182A (ja) 2004-10-21
ES2267840T3 (es) 2007-03-16
CA2431662A1 (en) 2002-07-11
WO2002053288A3 (en) 2002-12-12
US20040050784A1 (en) 2004-03-18
EP1345694B1 (en) 2006-08-02

Similar Documents

Publication Publication Date Title
AU2002235795A1 (en) A method for the manufacture of compositions containing low concentrations of salts
ATE496007T1 (de) Anionaustauschadsorptionverfahren
Jardine et al. Unsaturated transport processes in undisturbed heterogeneous porous media: II. Co‐contaminants
Pierce et al. Adsorption of arsenite on amorphous iron hydroxide from dilute aqueous solution
Sunda et al. Phytoplankton growth in nutrient rich seawater: Importance of copper-manganese cellular interactions
MX9801072A (es) Metodo para purificar virus por cromatografia.
AU2821195A (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
ATE200037T1 (de) Sauerstoffabsorbierer
Wedler et al. Glutamine synthetase of Bacillus stearothermophilus. I. Purification and basic properties
AU591397B2 (en) Method of preparing alpha-1-proteinase inhibitor
Tan et al. Combined effect of carbon dosage and initial adsorbate concentration on the adsorption isotherm of heavy metals on activated carbon
RU93051355A (ru) Способ регулирования железа в водной жидкости для гидроразрыва нефтяного пласта
ES8307102A1 (es) Un metodo para la absorcion de sustancias uremicas en un rinon artificial.
AU2002358607A1 (en) Method for renaturating proteins
Brady et al. Copper tolerance in Saccharomyces cerevisiae
NZ211497A (en) Anaerobic treatment of wastewater
Tekiner et al. Purification of urease from jack bean (Canavalia ensiformis) with copper (II) chelated poly (hydroxyethyl methacrylate‐N‐methacryloyl‐(l)‐histidine methyl ester) cryogels
SE0002688D0 (sv) Adsorption method and ligands
ES2543829T3 (es) Procedimiento para la preparación del inhibidor de proteinasa alfa-1
Hung et al. Investigation of the effect of added organic amine on the chromatography of tricyclic antidepressant drugs using reversed-phase chromatography on octadecylsilica with sodium lauryl sulphate as pairing ion
JP4565247B2 (ja) 高速液体クロマトグラフィーシステム
Cohen et al. The role of organic coatings in the enrichment of marine particles with selenium. The fixation of selenite on an adsorbed amino acid
JPS5287860A (en) Method of removing heavy metal ion in drainage
RU2084551C1 (ru) Способ извлечения хрома из растворов
JPS6456139A (en) Adsorbent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase